{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:27:33Z","timestamp":1793683653843,"version":"4.5.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.lpm.2020.104035","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T11:24:23Z","timestamp":1594034663000},"page":"104035","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Adult-onset IgA vasculitis (Henoch-Sch\u00f6nlein): Update on therapy"],"prefix":"10.1016","volume":"49","author":[{"given":"Federica","family":"Maritati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Canzian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paride","family":"Fenaroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Vaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lpm.2020.104035_bib0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"9341","key":"10.1016\/j.lpm.2020.104035_bib0360","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(02)11279-7","article-title":"Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins","volume":"360","author":"Gardner-Medwin","year":"2002","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.lpm.2020.104035_bib0365","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/MD.0000000000000019","article-title":"Henoch-Schonlein purpura in northern Spain: clinical spectrum of the disease in 417 patients from a single center","volume":"93","author":"Calvo-Rio","year":"2014","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.lpm.2020.104035_bib0370","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/01.ASN.0000013883.99976.22","article-title":"Henoch-Schonlein Purpura in adults: outcome and prognostic factors","volume":"13","author":"Pillebout","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.lpm.2020.104035_bib0375","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s00467-007-0623-y","article-title":"Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schonlein purpura","volume":"22","author":"Lau","year":"2007","journal-title":"Pediatr Nephrol"},{"issue":"12","key":"10.1016\/j.lpm.2020.104035_bib0380","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.autrev.2017.10.009","article-title":"New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schonlein purpura)","volume":"16","author":"Heineke","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"9","key":"10.1016\/j.lpm.2020.104035_bib0385","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1002\/art.40178","article-title":"Characteristics and Management of IgA Vasculitis (Henoch-Schonlein) in Adults: Data From 260 Patients Included in a French Multicenter Retrospective Survey","volume":"69","author":"Audemard-Verger","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.lpm.2020.104035_bib0390","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0016-5107(02)70376-3","article-title":"GI involvement in Henoch-Schonlein purpura","volume":"56","author":"Esaki","year":"2002","journal-title":"Gastrointest Endosc"},{"issue":"11","key":"10.1016\/j.lpm.2020.104035_bib0395","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/ndt\/12.11.2277","article-title":"Long-term prognosis of Henoch-Schonlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schonlein purpura","volume":"12","author":"Coppo","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.lpm.2020.104035_bib0400","first-page":"1","article-title":"Comparing immunoglobulin A vasculitis (Henoch-Schonlein purpura) in children and adults: a single-centre study from Turkey","author":"Batu","year":"2018","journal-title":"Scand J Rheumatol"},{"issue":"11","key":"10.1016\/j.lpm.2020.104035_bib0405","first-page":"1179","article-title":"Course of Henoch-Schonlein nephritis after renal transplantation. Report on ten patients and review of the literature","volume":"58","author":"Meulders","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.lpm.2020.104035_bib0410","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1749-6632.2009.04674.x","article-title":"Colchicine revisited","volume":"1173","author":"Bhat","year":"2009","journal-title":"Ann N Y Acad Sci"},{"issue":"2 Pt 1","key":"10.1016\/j.lpm.2020.104035_bib0415","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0190-9622(85)70158-2","article-title":"Colchicine is effective in controlling chronic cutaneous leukocytoclastic vasculitis","volume":"13","author":"Callen","year":"1985","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.lpm.2020.104035_bib0420","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00431-015-2594-5","article-title":"Efficacy of colchicine in a child with relapsing bullous Henoch-Schonlein purpura","volume":"175","author":"Allali","year":"2016","journal-title":"Eur J Pediatr"},{"issue":"8","key":"10.1016\/j.lpm.2020.104035_bib0425","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1177\/0009922809337532","article-title":"Successful treatment of prolonged Henoch-Schonlein purpura with colchicine","volume":"48","author":"Saulsbury","year":"2009","journal-title":"Clin Pediatr (Phila)"},{"issue":"12","key":"10.1016\/j.lpm.2020.104035_bib0430","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/rheumatology\/40.12.1430","article-title":"Colchicine for the treatment of recurrent Henoch-Schonlein purpura in an adult","volume":"40","author":"Pyne","year":"2001","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.lpm.2020.104035_bib0435","first-page":"482","article-title":"Successful treatment of chronic Henoch-Schonlein purpura with colchicine and aspirin","volume":"2","author":"Padeh","year":"2000","journal-title":"Isr Med Assoc J"},{"issue":"9","key":"10.1016\/j.lpm.2020.104035_bib0440","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1136\/adc.2004.061598","article-title":"Dapsone therapy for Henoch-Schonlein purpura: a case series","volume":"90","author":"Iqbal","year":"2005","journal-title":"Arch Dis Child"},{"issue":"4","key":"10.1016\/j.lpm.2020.104035_bib0445","first-page":"220","article-title":"Dapsone for the treatment of chronic IgA vasculitis (Henoch-Schonlein)","volume":"71","author":"Bech","year":"2013","journal-title":"Neth J Med"},{"issue":"2","key":"10.1016\/j.lpm.2020.104035_bib0450","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1346-8138.2005.tb00729.x","article-title":"Adult Henoch-Schonlein purpura with severe abdominal pain treated with dapsone and factor XIII concentrate","volume":"32","author":"Shimomura","year":"2005","journal-title":"J Dermatol"},{"issue":"2","key":"10.1016\/j.lpm.2020.104035_bib0455","doi-asserted-by":"crossref","first-page":"154","DOI":"10.5507\/bp.2017.044","article-title":"Dapsone treatment is efficient against persistent cutaneous and gastrointestinal symptoms in children with Henoch-Schonlein purpura","volume":"162","author":"Volejnikova","year":"2018","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"issue":"2","key":"10.1016\/j.lpm.2020.104035_bib0460","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jpeds.2006.03.024","article-title":"Early prednisone therapy in Henoch-Schonlein purpura: a randomized, double-blind, placebo-controlled trial","volume":"149","author":"Ronkainen","year":"2006","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.lpm.2020.104035_bib0465","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1542\/peds.2007-0667","article-title":"Effects of corticosteroid on Henoch-Schonlein purpura: a systematic review","volume":"120","author":"Weiss","year":"2007","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.lpm.2020.104035_bib0470","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1136\/adc.2009.182394","article-title":"Renal manifestations of Henoch-Schonlein purpura in a 6-month prospective study of 223 children","volume":"95","author":"Jauhola","year":"2010","journal-title":"Arch Dis Child"},{"issue":"11","key":"10.1016\/j.lpm.2020.104035_bib0475","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/adc.2009.167874","article-title":"Clinical course of extrarenal symptoms in Henoch-Schonlein purpura: a 6-month prospective study","volume":"95","author":"Jauhola","year":"2010","journal-title":"Arch Dis Child"},{"issue":"10","key":"10.1016\/j.lpm.2020.104035_bib0480","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1136\/archdischild-2013-303642","article-title":"Randomised, double-blind, placebo-controlled trial to determine whether steroids reduce the incidence and severity of nephropathy in Henoch-Schonlein Purpura (HSP)","volume":"98","author":"Dudley","year":"2013","journal-title":"Arch Dis Child"},{"issue":"3","key":"10.1016\/j.lpm.2020.104035_bib0485","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s004670050446","article-title":"Methylprednisolone pulse therapy in the treatment of severe forms of Schonlein-Henoch purpura nephritis","volume":"12","author":"Niaudet","year":"1998","journal-title":"Pediatr Nephrol"},{"issue":"9156","key":"10.1016\/j.lpm.2020.104035_bib0490","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0140-6736(98)03563-6","article-title":"Corticosteroids in IgA nephropathy: a randomised controlled trial","volume":"353","author":"Pozzi","year":"1999","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.lpm.2020.104035_bib0495","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/01.ASN.0000103869.08096.4F","article-title":"Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial","volume":"15","author":"Pozzi","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.lpm.2020.104035_bib0500","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/ki.2012.280","article-title":"The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines--application to the individual patient","volume":"82","author":"Radhakrishnan","year":"2012","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.lpm.2020.104035_bib0505","first-page":"9","article-title":"Response of crescentic Henoch-Schoenlein purpura nephritis to corticosteroid and azathioprine therapy","volume":"49","author":"Bergstein","year":"1998","journal-title":"Clin Nephrol"},{"issue":"3","key":"10.1016\/j.lpm.2020.104035_bib0510","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1067\/mpd.2000.103448","article-title":"Effective therapy for severe Henoch-Schonlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study","volume":"136","author":"Foster","year":"2000","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.lpm.2020.104035_bib0515","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00296-002-0208-9","article-title":"Severe Henoch-Schonlein nephritis: resolution with azathioprine and steroids","volume":"22","author":"Singh","year":"2002","journal-title":"Rheumatol Int"},{"issue":"8","key":"10.1016\/j.lpm.2020.104035_bib0520","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00467-005-1869-x","article-title":"Can azathioprine and steroids alter the progression of severe Henoch-Schonlein nephritis in children?","volume":"20","author":"Shin","year":"2005","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"10.1016\/j.lpm.2020.104035_bib0525","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s00467-007-0557-4","article-title":"Outcome of Henoch-Schonlein purpura nephritis treated with long-term immunosuppression","volume":"22","author":"Shenoy","year":"2007","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1016\/j.lpm.2020.104035_bib0530","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00467-010-1741-5","article-title":"Treatment strategies for Henoch-Schonlein purpura nephritis by histological and clinical severity","volume":"26","author":"Ninchoji","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1016\/j.lpm.2020.104035_bib0535","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.semarthrit.2005.08.007","article-title":"Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature","volume":"35","author":"Trapani","year":"2005","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.lpm.2020.104035_bib0540","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12969-016-0100-x","article-title":"Azathioprine therapy for steroid-resistant Henoch-Schonlein purpura: a report of 6 cases","volume":"14","author":"Fotis","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"issue":"6","key":"10.1016\/j.lpm.2020.104035_bib0545","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1053\/j.ajkd.2016.11.027","article-title":"Mycophenolate mofetil combined with prednisone versus full-dose prednisone in IgA nephropathy with active proliferative lesions: a randomized controlled trial","volume":"69","author":"Hou","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.lpm.2020.104035_bib0550","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/ki.2009.499","article-title":"Long-term study of mycophenolate mofetil treatment in IgA nephropathy","volume":"77","author":"Tang","year":"2010","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.lpm.2020.104035_bib0555","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00467-011-2057-9","article-title":"Treatment of children with Henoch-Schonlein purpura nephritis with mycophenolate mofetil","volume":"27","author":"Du","year":"2012","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1016\/j.lpm.2020.104035_bib0560","doi-asserted-by":"crossref","first-page":"858","DOI":"10.4103\/1319-2442.135182","article-title":"Treatment of severe henoch-schonlein purpura nephritis with mycophenolate mofetil","volume":"25","author":"Nikibakhsh","year":"2014","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"3","key":"10.1016\/j.lpm.2020.104035_bib0565","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000341914","article-title":"The combination of mycophenolate mofetil with corticosteroids induces remission of Henoch-Schonlein purpura nephritis","volume":"36","author":"Ren","year":"2012","journal-title":"Am J Nephrol"},{"issue":"9","key":"10.1016\/j.lpm.2020.104035_bib0570","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1631\/jzus.B1400335","article-title":"Mycophenolate mofetil plus prednisone for inducing remission of Henoch-Schonlein purpura nephritis: a retrospective study","volume":"16","author":"Han","year":"2015","journal-title":"J Zhejiang Univ Sci B"},{"issue":"11","key":"10.1016\/j.lpm.2020.104035_bib0575","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1007\/s00467-003-1245-7","article-title":"Cyclosporin A for the treatment of severe Henoch-Schonlein glomerulonephritis","volume":"18","author":"Ronkainen","year":"2003","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1016\/j.lpm.2020.104035_bib0580","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1328-0867.2004.01842.x","article-title":"Cyclosporine A for heavy proteinuria in a child with Henoch-Schonlein purpura nephritis","volume":"46","author":"Someya","year":"2004","journal-title":"Pediatr Int"},{"issue":"8","key":"10.1016\/j.lpm.2020.104035_bib0585","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00467-005-1864-2","article-title":"Cyclosporin A therapy for severe Henoch-Schonlein nephritis with nephrotic syndrome","volume":"20","author":"Shin","year":"2005","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1016\/j.lpm.2020.104035_bib0590","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00467-010-1723-7","article-title":"Cyclosporin A therapy for Henoch-Schonlein nephritis with nephrotic-range proteinuria","volume":"26","author":"Park","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"12","key":"10.1016\/j.lpm.2020.104035_bib0595","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s00467-011-1919-5","article-title":"Cyclosporine A vs. methylprednisolone for Henoch-Schonlein nephritis: a randomized trial","volume":"26","author":"Jauhola","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1016\/j.lpm.2020.104035_bib0600","doi-asserted-by":"crossref","first-page":"380","DOI":"10.5414\/CN106553","article-title":"Cyclosporin A in adult patients with Henoch-Schonlein purpura nephritis and nephrotic syndrome; 5 case reports","volume":"75","author":"Kalliakmani","year":"2011","journal-title":"Clin Nephrol"},{"issue":"20","key":"10.1016\/j.lpm.2020.104035_bib0605","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.2169\/internalmedicine.0931-18","article-title":"Successful treatment of IgA vasculitis complicated with bowel perforation and crescentic glomerulonephritis by combination therapy of glucocorticoid, cyclosporine and factor XIII replacement","volume":"57","author":"Koshiba","year":"2018","journal-title":"Intern Med"},{"issue":"1","key":"10.1016\/j.lpm.2020.104035_bib0610","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00467-003-1315-x","article-title":"Henoch-Schonlein purpura nephritis: course of disease and efficacy of cyclophosphamide","volume":"19","author":"Tarshish","year":"2004","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"10.1016\/j.lpm.2020.104035_bib0615","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ki.2010.150","article-title":"Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Schonlein Purpura","volume":"78","author":"Pillebout","year":"2010","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.lpm.2020.104035_bib0620","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/ndt\/gft318","article-title":"Impact of rituximab trials on the treatment of ANCA-associated vasculitis","volume":"29","author":"Alberici","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.lpm.2020.104035_bib0625","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jpeds.2008.12.049","article-title":"Rituximab therapy for severe refractory chronic Henoch-Schonlein purpura","volume":"155","author":"Donnithorne","year":"2009","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.lpm.2020.104035_bib0630","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1093\/ndt\/gfr137","article-title":"Successful outcome using rituximab as the only immunomodulation in Henoch-Schonlein purpura: case report","volume":"26","author":"Pillebout","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.lpm.2020.104035_bib0635","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s12026-016-8827-5","article-title":"Rituximab therapy for IgA-vasculitis with nephritis: a case series and review of the literature","volume":"65","author":"Fenoglio","year":"2017","journal-title":"Immunol Res"},{"issue":"1","key":"10.1016\/j.lpm.2020.104035_bib0640","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/art.40339","article-title":"Brief Report: rituximab for the treatment of adult-onset IgA vasculitis (Henoch-Schonlein)","volume":"70","author":"Maritati","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.lpm.2020.104035_bib0645","doi-asserted-by":"crossref","first-page":"476","DOI":"10.7326\/0003-4819-120-6-199403150-00005","article-title":"High-dose immunoglobulin therapy for severe IgA nephropathy and Henoch-Schonlein purpura","volume":"120","author":"Rostoker","year":"1994","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.lpm.2020.104035_bib0650","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000188480","article-title":"Immunomodulation with low-dose immunoglobulins for moderate IgA nephropathy and Henoch-Schonlein purpura. Preliminary results of a prospective uncontrolled trial","volume":"69","author":"Rostoker","year":"1995","journal-title":"Nephron"},{"issue":"3","key":"10.1016\/j.lpm.2020.104035_bib0655","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0272-6386(99)70178-2","article-title":"Plasmapheresis as the sole therapy for rapidly progressive Henoch-Schonlein purpura nephritis in children","volume":"33","author":"Hattori","year":"1999","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1016\/j.lpm.2020.104035_bib0660","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s00467-004-1514-0","article-title":"Plasmapheresis therapy for rapidly progressive Henoch-Schonlein nephritis","volume":"19","author":"Kawasaki","year":"2004","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"10.1016\/j.lpm.2020.104035_bib0665","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00467-007-0498-y","article-title":"Treating severe Henoch-Schonlein and IgA nephritis with plasmapheresis alone","volume":"22","author":"Shenoy","year":"2007","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"10.1016\/j.lpm.2020.104035_bib0670","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1053\/j.ajkd.2011.12.015","article-title":"Addition of plasma exchange to glucocorticosteroids for the treatment of severe Henoch-Schonlein purpura in adults: a case series","volume":"59","author":"Augusto","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1016\/j.lpm.2020.104035_bib0675","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1365-2222.2004.02029.x","article-title":"Urinary leukotriene E4 in Henoch-Schonlein purpura","volume":"34","author":"Tsuji","year":"2004","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.lpm.2020.104035_bib0680","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/ped.12271","article-title":"Add-on therapy with montelukast in the treatment of Henoch-Schonlein purpura","volume":"56","author":"Wu","year":"2014","journal-title":"Pediatr Int"},{"issue":"10","key":"10.1016\/j.lpm.2020.104035_bib0685","doi-asserted-by":"crossref","first-page":"e0185880","DOI":"10.1371\/journal.pone.0185880","article-title":"Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: a randomised trial","volume":"12","author":"Maritati","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.lpm.2020.104035_bib0690","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/0036933018809816","article-title":"Recurrent Henoch Schonlein purpura without renal involvement successfully treated with methotrexate","volume":"64","author":"Miray Kisla Ekinci","year":"2019","journal-title":"Scott Med J"},{"issue":"6","key":"10.1016\/j.lpm.2020.104035_bib0695","first-page":"767","article-title":"Methotrexate used as a steroid-sparing agent in non-renal chronic Henoch-Schonlein purpura","volume":"21","author":"Rettig","year":"2003","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"10.1016\/j.lpm.2020.104035_bib0700","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00296-017-3685-6","article-title":"Efficacy of mizoribine and prednisolone combination therapy in adult patients with IgA vasculitis","volume":"37","author":"Mima","year":"2017","journal-title":"Rheumatol Int"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498220300233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498220300233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:06:54Z","timestamp":1760105214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498220300233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0755498220300233"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2020.104035","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adult-onset IgA vasculitis (Henoch-Sch\u00f6nlein): Update on therapy","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2020.104035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104035"}}